EAGER: Targeted and specific elimination of plant chromosomes
EAGER:有针对性地、特异性地消除植物染色体
基本信息
- 批准号:2310320
- 负责人:
- 金额:$ 29.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
In this rapidly changing and drying world, the rapid breeding and development of climate-adapted crop varieties is a necessary foundation of US national competitiveness and sustainability. This proposal takes genome editing by CRISPR from its preponderant use of modification or alteration of one or few genes, to a novel tool for genome-scale alterations that are urgently needed to accelerate breeding. The development of this novel technology can impact the breeding of multiple crops, including allopolyploid ones, such as wheat, canola, and peanut, that can be notoriously challenging due to their genomic complexity, but are critical components of US’s staple foods. In terms of outreach, undergraduate and graduate students will be trained in advanced plant genomics and molecular biology in the context of this project. Additionally, it will provide opportunities for exposing underrepresented groups to STEM-related work through dissemination of the concepts, methods and societal implications of this work through publications, presentations and / or outreach videos geared towards the general public and, specifically, younger audiences.The strategy entails targeting CRISPR to hand-picked sets of chromosomal sequences, so that “immune” chromosomes survive, while targeted chromosomes are eliminated. This results in individuals with specific, desirable chromosome sets, such as those from a given parent. The objectives are to demonstrate and optimize accession-specific chromosome elimination and to engineer elimination of a parental chromosome set in tomato, effectively resulting in haploid induction. Using both the model arabidopsis and the crop tomato, the work involves development of methods for identification of accession- and chromosome-specific CRISPR targets, for rapid validation of these targets, and for engineering of genotype- and karyotype-specific drives. Genome-scale alterations of crop genomes through Targeted Elimination of Chromosomes (TEC), could potentially enable broad application of haploid induction, manipulation of allopolyploid genome, and selection of specific genome-wide haplotypic configurations in hybrid progeny.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
在这个快速变化和干燥的世界中,快速培育和开发适应气候的作物品种是美国国家竞争力和可持续性的必要基础。该提案将CRISPR的基因组编辑从其对一个或几个基因的修饰或改变的优势用途,转变为加速育种迫切需要的基因组规模改变的新工具。这项新技术的发展可以影响多种作物的育种,包括小麦、油菜和花生等异源多倍体作物,这些作物由于基因组的复杂性而具有众所周知的挑战性,但它们是美国主食的关键组成部分。在外联方面,本科生和研究生将在本项目范围内接受先进植物基因组学和分子生物学方面的培训。此外,它还将通过面向公众,特别是年轻受众的出版物、演示文稿和/或宣传视频,传播这项工作的概念、方法和社会影响,为代表性不足的群体提供接触STEM相关工作的机会。该战略需要将CRISPR瞄准精心挑选的染色体序列集,以便“免疫”染色体存活,而目标染色体被消除。这导致个体具有特定的、理想的染色体组,例如来自给定父母的染色体组。目的是证明和优化加入特定的染色体消除和工程消除的亲本染色体组在番茄,有效地导致单倍体诱导。使用拟南芥和番茄这两种模型,这项工作涉及开发用于鉴定登录和染色体特异性CRISPR靶点的方法,用于快速验证这些靶点,以及用于基因型和核型特异性驱动的工程化。通过定向消除染色体(TEC)对作物基因组进行基因组规模的改变,有可能使单倍体诱导、异源多倍体基因组操作以及在杂交后代中选择特定的全基因组单倍型构型的广泛应用成为可能。该奖项反映了NSF的法定使命,并通过使用基金会的智力价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luca Comai其他文献
The advantages and disadvantages of being polyploid
多倍体的优缺点
- DOI:
10.1038/nrg1711 - 发表时间:
2005-10-11 - 期刊:
- 影响因子:52.000
- 作者:
Luca Comai - 通讯作者:
Luca Comai
Genetic and epigenetic interactions in allopolyploid plants
- DOI:
10.1023/a:1006480722854 - 发表时间:
2000-01-01 - 期刊:
- 影响因子:3.800
- 作者:
Luca Comai - 通讯作者:
Luca Comai
Chromoanagenesis in plants: triggers, mechanisms, and potential impact
植物中的染色体进化:触发因素、机制和潜在影响
- DOI:
10.1016/j.tig.2022.08.003 - 发表时间:
2023-01-01 - 期刊:
- 影响因子:16.300
- 作者:
Weier Guo;Luca Comai;Isabelle M. Henry - 通讯作者:
Isabelle M. Henry
Chromosome-scale assembly of apple mint (Mentha suaveolens)
- DOI:
10.1186/s12863-024-01278-y - 发表时间:
2024-11-08 - 期刊:
- 影响因子:2.500
- 作者:
Alana Firl;Meric C. Lieberman;Nestor Kippes;Helen Tsai;Eric Dowd;Luca Comai;Isabelle M. Henry - 通讯作者:
Isabelle M. Henry
「柿」で見つかった性決定因子の示す可能性
“柿子”中发现性别决定因素的可能性
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Takashi Akagi;Isabelle M. Henry;Ryutaro Tao;Luca Comai;赤木剛士・Isabelle M Henry・Luca Comai・田尾龍太郎;赤木剛士 - 通讯作者:
赤木剛士
Luca Comai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luca Comai', 18)}}的其他基金
RESEARCH-PGR: Mechanisms of Haploid Induction in Potato
研究-PGR:马铃薯单倍体诱导机制
- 批准号:
2055260 - 财政年份:2021
- 资助金额:
$ 29.81万 - 项目类别:
Standard Grant
RESEARCH-PGR: Variants and Recombinants without Meiosis
研究-PGR:无减数分裂的变体和重组体
- 批准号:
1956429 - 财政年份:2020
- 资助金额:
$ 29.81万 - 项目类别:
Standard Grant
Rapid and Targeted Introgression of Traits via Genome Elimination
通过基因组消除快速、有针对性的性状渗入
- 批准号:
1444612 - 财政年份:2015
- 资助金额:
$ 29.81万 - 项目类别:
Continuing Grant
(B7N) - A Low Impact, High Efficiency Transformation Marker System
(B7N) - 低影响、高效率的转化标记系统
- 批准号:
1354564 - 财政年份:2013
- 资助金额:
$ 29.81万 - 项目类别:
Standard Grant
The Regulatory Disruption Hypothesis for Heterosis
杂种优势的监管破坏假说
- 批准号:
0924025 - 财政年份:2009
- 资助金额:
$ 29.81万 - 项目类别:
Standard Grant
Efficient Identification of Induced Mutations in Crop Species by Ultra-High Throughput DNA Sequencing
通过超高通量 DNA 测序有效鉴定作物物种中的诱导突变
- 批准号:
0822383 - 财政年份:2008
- 资助金额:
$ 29.81万 - 项目类别:
Standard Grant
Functional Genomics of Plant Polyploids
植物多倍体的功能基因组学
- 批准号:
0733857 - 财政年份:2006
- 资助金额:
$ 29.81万 - 项目类别:
Cooperative Agreement
Functional Genomics of Plant Polyploids
植物多倍体的功能基因组学
- 批准号:
0501712 - 财政年份:2005
- 资助金额:
$ 29.81万 - 项目类别:
Cooperative Agreement
Arabidopsis 2010: ATP: A Reverse Genetics Service for the Arabidopsis Community
拟南芥 2010:ATP:拟南芥群落的反向遗传学服务
- 批准号:
0313369 - 财政年份:2003
- 资助金额:
$ 29.81万 - 项目类别:
Standard Grant
Characterization and Role of SAR Elements Flanking the HSC80Locus of Tomato
番茄 HSC80 基因座两侧 SAR 元件的特征和作用
- 批准号:
9205573 - 财政年份:1992
- 资助金额:
$ 29.81万 - 项目类别:
Continuing Grant
相似国自然基金
柳枝稷miR156-targeted PvSPLs调控木质素合成的分子机制研究
- 批准号:31701496
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
miR156-targeted PvSPL转录因子调控柳枝稷分蘖发育的分子机制
- 批准号:31672479
- 批准年份:2016
- 资助金额:65.0 万元
- 项目类别:面上项目
相似海外基金
Targeted pathogen-specific nanomaterials for delivery and biosensor applications within plants
用于植物内递送和生物传感器应用的靶向病原体特异性纳米材料
- 批准号:
24K17831 - 财政年份:2024
- 资助金额:
$ 29.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted Delivery of Biodistribution-Guided Recombinant Adeno-associated Viral Vector (AAV) to Specific Hepatocytes
将生物分布引导的重组腺相关病毒载体 (AAV) 靶向递送至特定肝细胞
- 批准号:
24K18551 - 财政年份:2024
- 资助金额:
$ 29.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:
10551184 - 财政年份:2023
- 资助金额:
$ 29.81万 - 项目类别:
Development of practical screening tools to support targeted prevention of early, high-risk drinking substance use
开发实用的筛查工具,以支持有针对性地预防早期高风险饮酒物质的使用
- 批准号:
10802793 - 财政年份:2023
- 资助金额:
$ 29.81万 - 项目类别:
Engineering Siglec15/TGF-beta targeted bispecific antibodies that modulate the tumor microenvironment and enhances T-cell immunotherapy against pancreatic cancer
工程化 Siglec15/TGF-β 靶向双特异性抗体可调节肿瘤微环境并增强针对胰腺癌的 T 细胞免疫治疗
- 批准号:
10651442 - 财政年份:2023
- 资助金额:
$ 29.81万 - 项目类别:
Optimizing outcomes for children and young adults with relapse of B-cell acute lymphoblastic leukemia after CD19-targeted chimeric antigen receptor T-cell therapy
优化 CD19 靶向嵌合抗原受体 T 细胞治疗后 B 细胞急性淋巴细胞白血病复发的儿童和年轻人的结局
- 批准号:
10572071 - 财政年份:2023
- 资助金额:
$ 29.81万 - 项目类别:
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Allograft Endothelium
针对人同种异体移植物内皮的体外纳米颗粒药物输送
- 批准号:
10783379 - 财政年份:2023
- 资助金额:
$ 29.81万 - 项目类别:
Mitochondrial-Targeted Therapy for Macular Degeneration
线粒体靶向治疗黄斑变性
- 批准号:
10602150 - 财政年份:2023
- 资助金额:
$ 29.81万 - 项目类别:
Mapping tumor specific immunopeptidome for antibody-based targeted therapy
绘制肿瘤特异性免疫肽组用于基于抗体的靶向治疗
- 批准号:
10604941 - 财政年份:2023
- 资助金额:
$ 29.81万 - 项目类别:
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
PI3K 靶向 T 细胞介导的持久抗肿瘤免疫机制
- 批准号:
10682190 - 财政年份:2023
- 资助金额:
$ 29.81万 - 项目类别: